CLNN

CLNN

USD

Clene Inc. Common Stock

$3.590-0.170 (-4.521%)

Reaalajas hind

Consumer Defensive
Pakendatud toidud
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$3.760

Kõrge

$3.760

Madal

$3.540

Maht

0.02M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

32.2M

Tööstusharu

Pakendatud toidud

Riik

United States

Kauplemisstatistika

Keskmine maht

0.09M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $2.28Praegune $3.590Kõrge $6.96

Seotud uudised

Analyst Upgrades

Jones Trading Initiates Coverage On Clene with Buy Rating, Announces Price Target of $30

Jones Trading analyst Justin Walsh initiates coverage on Clene with a Buy rating and announces Price Target of $30.

Vaata rohkem
Jones Trading Initiates Coverage On Clene with Buy Rating, Announces Price Target of $30
GlobeNewswire

Clene to Present at the Emerging Growth Conference

SALT LAKE CITY, April 14, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company

Vaata rohkem
Clene to Present at the Emerging Growth Conference
Analyst Upgrades

D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target

D. Boral Capital analyst Jason Kolbert maintains Clene with a Buy and maintains $23 price target.

Vaata rohkem
D. Boral Capital Maintains Buy on Clene, Maintains $23 Price Target
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Clene, Maintains $31 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene with a Buy and maintains $31 price target.

Vaata rohkem
HC Wainwright & Co. Reiterates Buy on Clene, Maintains $31 Price Target